Amaye sur Orne, France

Thomas Freret

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Université De Caen. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Freret. Retrieved from https://idiyas.com/inventor/thomas-freret

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Freret: Innovator in Pharmaceutical Chemistry

Introduction

Thomas Freret is a notable inventor based in Amaye sur Orne, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Freret holds a patent for "Acetylcholinesterase inhibitors and promnesiant serotonin 5-HT4 receptor agonists, their methods of preparation and the pharmaceutical compositions containing the same." This patent includes compounds represented by Formula (I) along with their enantiomers, racemics, acid salts, hydrates, and solvation products. The invention details methods for preparing these compounds and the pharmaceutical compositions that incorporate them.

Career Highlights

Throughout his career, Thomas Freret has worked with esteemed institutions such as Université de Caen. His research has focused on innovative approaches to drug development, particularly in the realm of neuropharmacology.

Collaborations

Freret has collaborated with notable colleagues, including Patrick Dallemagne and Christophe Rochais. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Thomas Freret's work in pharmaceutical chemistry exemplifies the impact of innovation in drug development. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…